Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATE: Sequential Ticagrelor and Clopidogrel Monotherapy in ACS
NCT04937699Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor, clopidogrel in acute coronary syndrome (ACS), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Mar 2023; status: recruiting.
02
Drugs
ticagrelorclopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04937699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04937699.